$20.90
-0.13-0.62%
Last update: Nov 9, 1:40 PM

vTv Therapeutics (VTVT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.07 | $-0.94 | $0.24 | $-1.04 |
| Actual | $-0.94 | $-1.05 | $1.65 | $-0.58 |
| Surprise | +12.2% | -11.7% | +587.5% | +44.2% |
| Revenue | ||||
| Estimate | $225000 | $320000 | $12.0M | — |
| Actual | $0 | $0 | $36.8M | — |
| Surprise | -100.0% | -100.0% | +207.0% | — |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-1.16 | $-1.09 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-0.94 | $-1.07 | 12.2 % |
| Q2 | Aug 6, 2026 | $-1.05 | $-0.94 | -11.7 % |
| Q1 | May 13, 2026 | $1.65 | $0.24 | 587.5 % |
| Q4 | Mar 10, 2026 | $-0.58 | $-1.04 | 44.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $0 | $225.00K | -100.0 % |
| Q2 | Aug 6, 2026 | $0 | $320.00K | -100.0 % |
| Q1 | May 13, 2026 | $36.84M | $12.00M | 207.0 % |
| Q4 | Mar 29, 2022 | $9.00K | $1.00M | -99.1 % |